KIAA1704, a designation often used in the context of human genetics and proteomics, refers to a protein encoded by a gene identified in large-scale sequencing projects, particularly those originating from the Kazusa DNA Research Institute in Japan. The acronym "KIAA" stands for Kazusa Institute cDNA sequencing project, and the numbers that follow correspond to the specific cDNA clone in their library. Proteins like KIAA1704 are usually characterized by having relatively little information available about their function, structure, or role in the cell when first identified.
The KIAA1704 protein, like many proteins initially identified through these sequencing efforts, is typically subjected to further bioinformatics analysis and experimental studies to elucidate its biological significance. This includes investigating its expression patterns, cellular localization, post-translational modifications, and potential interactions with other proteins. Additionally, researchers may explore the evolutionary conservation of the protein to predict its importance and potential functions.Due to the preliminary nature of the information available for KIAA1704, its functions and interactions are not well-defined, making it a subject of ongoing scientific inquiry. Scientists may use a variety of techniques, such as gene knockdown or overexpression studies, to determine the phenotypic consequences of altering KIAA1704 levels in cells or organisms. Moreover, protein-protein interaction assays could reveal the molecular pathways KIAA1704 may be involved in.
Items 1 to 10 of 12 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | ¥2414.00 ¥3565.00 ¥4716.00 | 7 | |
DNA 甲基转移酶抑制剂可能会改变基因表达模式,从而影响 FAM208A。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | ¥1681.00 ¥5303.00 ¥6995.00 ¥13527.00 ¥23579.00 | 33 | |
组蛋白去乙酰化酶抑制剂,可影响染色质重塑和基因表达,从而可能影响 FAM208A。 | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | ¥338.00 ¥519.00 ¥925.00 ¥2459.00 | 19 | |
影响组蛋白乙酰化,从而可能影响包括 FAM208A 在内的基因表达。 | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | ¥959.00 | 9 | |
作为组蛋白去乙酰化酶抑制剂,可能会影响与 FAM208A 相关的基因表达。 | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | ¥406.00 ¥767.00 ¥1207.00 ¥2414.00 ¥2640.00 ¥9725.00 ¥22203.00 | 47 | |
调节各种细胞通路,可能通过表观遗传变化影响 FAM208A。 | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | ¥699.00 ¥1749.00 ¥3610.00 | 233 | |
mTOR 抑制剂可能会影响与 FAM208A 功能相关的细胞过程。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | ¥2414.00 | ||
影响 Wnt 信号转导,这可能与涉及 FAM208A 的途径有交叉。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | ¥733.00 ¥3599.00 ¥6487.00 ¥11259.00 | 28 | |
影响基因表达,可能影响与 FAM208A 相关的通路。 | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | ¥1467.00 ¥3046.00 | 37 | |
另一种组蛋白去乙酰化酶抑制剂可能会影响与 FAM208A 相关的染色质结构和基因表达。 | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | ¥767.00 | 2 | |
自噬抑制剂,可能影响与 FAM208A 相关的细胞通路。 |